We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for post-16 providers on the next steps towards delivery of T Levels.
Information for post-16 institutions considering expressing an interest to deliver T Levels in 2021 to 2022 academic year including the transition offer.
Funding guidance for T Level providers.
Information on how Ofqual is regulating the technical qualification component of T Levels.
Information for post-16 institutions considering expressing an interest to deliver the first 3 T levels in 2020 to 2021 academic year.
Information for post-16 providers on how to register to offer T Levels for the first time in the 2026 to 2027 academic year.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
An approach to payment for providers of IAPT services that links payment to patient outcomes as well as the provider’s levels of activity.
How to use a before-and-after study to evaluate your digital health product.
Progress on the rollout of T Levels and actions being taken to scale up the programme.
We’re responsible for handling applications for the discharge of patients detained in psychiatric hospitals. We also handle applications to change community treatment orders and the conditions placed on a ‘conditional discharge’ from hospital. Who we are We are part of...
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
The Vaccine Development Evaluation Centre (VDEC) at Porton Down in Wiltshire facilitates the development and evaluation of new vaccines and therapeutics.
This guidance provides information on comparator products used in studies supporting abridged marketing authorisation applications
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.